Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done.
20 likes 23mo
Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done.
Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is extrapolating beyond the data.
I would treat the number as indicative rather than as a measurement.
Fair, and the limits you put on it are the part I will remember.
Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating.
Read the full topic (24 posts)
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Athletes in weight-category sports: a different risk calculus — a second dataset
On the subject in the title: Athletes in weight-category sports: a different risk calculus — a second dataset Working notes rather than a conclusion. Posting a small dataset on Athletes in weight-category…
|
+37 | 41 | 16k | 20mo |
|
Pregnancy and pregnancy planning: contraindication and washout
Posting this under the heading it deserves: Pregnancy and pregnancy planning: contraindication and washout Everything below is what sits behind that. Pregnancy and pregnancy planning: setting out the…
|
+111 | 122 | 2.4k | 3mo |
|
Coming back to: Bariatric surgery history: altered anatomy, altered expectations
Bariatric surgery history: altered anatomy, altered expectations Writing it up because I had to work it out twice and would rather nobody else did. Bariatric surgery history — I have the observation and I do…
|
2 | 38k | 15mo | |
|
People with a low starting BMI: where the evidence stops
Posting this under the heading it deserves: People with a low starting BMI: where the evidence stops Everything below is what sits behind that. Asking about a population rather than about a person. The…
|
+23 | 27 | 5.8k | 19mo |
|
Type 1 diabetes: off-label use and the evidence gap — what changed since
Type 1 diabetes: off-label use and the evidence gap — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Type 1 diabetes is wrong?…
|
+68 | 77 | 31k | 20mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Hypertension improvement and when medication needs revisiting
Hypertension improvement and when medication needs revisiting Writing it up because I had to work it out twice and would rather nobody else did. Hypertension improvement: setting out the arithmetic in full,…
|
+74 | 79 | 1.1k | 10mo |
|
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. Working notes on Heart failure with preserved ejection rather…
|
+4 | 8 | 43k | 17mo |
|
Pregnancy as an absolute contraindication
Pregnancy as an absolute contraindication — setting out what I have, and where I think it stops being reliable. Pregnancy keeps being re-asked here and I think that is because the answer is conditional and…
|
+102 | 106 | 21k | 14mo |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count…
|
+18 | 25 | 1.7k | 22mo |
|
Coming back to: Renal impairment: what the labelling says about dose
Renal impairment: what the labelling says about dose — setting out what I have, and where I think it stops being reliable. Renal impairment — I have the observation and I do not trust my interpretation of it,…
|
+30 | 34 | 48k | 18mo |